Scalper1 News
Abbott Laboratories’ (ABT) first-quarter revenue and earnings dipped, but earnings still topped analyst estimates, sending shares slightly higher Wednesday. The medical products giant reported a 2.4% fall in earnings to 41 cents per share. But this still topped the 36 cents per share analysts polled by Thomson Reuters were expecting. Revenue dipped 2.5% to $5.24 billion, slightly less than views for $5.27 billion. Global sales fell 0.5% on an Scalper1 News
Scalper1 News